{
  "Figure": "nihms829669_page15_442.jpg",
  "Figure_title": "Figure 3.  Effects of romidepsin ± erlotinib on HDAC activity (A) Transient decrease in HDAC activity  after initiation of romidepsin and again after addition of erlotinib. (B) Individual patient data  showing HDAC activity level over time (n = 14). For normalized HDAC activity values,  mean decrease was 0.30 ± 0.16 in the 8 mg/m2 cohort (P < 0.01) and 0.40 ± 0.33 in the 10  mg/m2 cohort (P < 0.01). "
}